Authors


Nicole Grieselhuber, MD, PhD

Latest:

Stripped of Fucose, Powerful Monoclonal Antibody Shows Promising Results in MDS Dosing Study

Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who were treated with a combination of SEA-CD70 and azacitidine.


Caitlin McCarthy, PharmD, BCPP

Latest:

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.


Orly Vardeny, PharmD, MS

Latest:

Iron Deficiency and Cardiovascular Interventions

A panelist discusses how the multicenter ferric carboxymaltose trial employed a prospective design to evaluate iron supplementation's impact on heart failure outcomes, strategically selecting hospitalization reduction as the primary end point due to its clinical relevance and statistical power considerations.


Leah Kuntz

Latest:

Treating Depression to Prevent Dementia

According to new research, treating depression in older adults could decrease risk of dementia by 51%.


Geoff Neimark, MD

Latest:

The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality Collaborative

This article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.


Mark F. Pyfer, MD, Northern Ophthalmic Associates
Mark F. Pyfer, MD

Latest:

Contributor: Congress Must Do More to Cover Nonopioid Alternatives

Preventing addiction is key to ending the opioid epidemic—2020 alone saw more than 93,000 overdose deaths—as are expanding access to treatment, promoting recovery, and building a multifaceted strategy that incorporates nonopioid alternative and their coverage by providers. Although appropriate in certain situations, opioids are not a one-size-fits-all approach.


Linda Shaughnessy, MBA

Latest:

Experience Incentivizing Reduction of Racial and Ethnic Disparities in a Medicaid Hospital Quality Incentive Program

Construction of a composite measure, use of a summary disparity statistic, and measure selection are key considerations in the design of equity-focused payment programs.


Morgan Greenwald, MA

Latest:

Preventive Care: Vaccines Matter

A database of information about more than 30,000 patients verified improved morbidity and mortality due to vaccines and preventive health care in prospective trials.


Galen Shearn-Nance, BS

Latest:

Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries

Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD, of Case Western Reserve University, acknowledge key limitations of their study and prioritize areas for further research.


Loretta Hsueh, PhD

Latest:

Primary Care Video and Telephone Telemedicine During the COVID-19 Pandemic: Treatment and Follow-up Health Care Utilization

Telephone visits may offer a simple and convenient option to address patient primary care needs without raising safety concerns.



Rachel Ombres, MD

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.


Bonnie LaPlante, MHA, RN

Latest:

Care Coordination in Primary Care: Mapping the Territory

A survey completed by 100% of leaders of diverse care systems in Minnesota participating in an observational study showed little difference in approach to care coordination.


Rhodri Saunders, PhD

Latest:

Clinical Outcomes in Heart Failure Monitoring: A Pooled Rates Analysis

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge.


Kimberly A. Muellers, MPH, MS

Latest:

Navigating Privacy and Security in Telemedicine for Primary Care

This qualitative study of patients and providers in primary care evaluated privacy and safety considerations in telemedicine following the COVID-19 pandemic.



Martin Edelman, MD

Latest:

Lingering Unknowns Amid Lung Cancer Breakthroughs: Martin Edelman, MD

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' abilities to anticipate patients' treatment responses.


Prasaad Ayyanar, MS

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Dawn Lobick, MSN, RN

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.


D. Campbell Liles, MD

Latest:

Operating Room Efficiency of Orthopedic Surgery During the COVID-19 Era

The authors analyzed the impacts of COVID-19 on orthopedic operating room efficiency via comparison of 14,856 surgeries performed before, during, and after the pandemic.


Lindsey A. Herrel, MD, MS

Latest:

Medicare Accountable Care Organizations Reduce Spending on Surgery

Medicare Shared Savings Program accountable care organizations spent less on surgical care by reducing inpatient surgery, increasing outpatient surgery, and reducing spending on postacute care after inpatient surgery.


Jennifer Payton, MHCA, BSN, RN, CNN

Latest:

Medicare Payment Rule Threatens Access to Life-Sustaining Kidney Care

The authors call on Congress to reform Medicare reimbursement for dialysis, saying the recent rule puts clinics at risk of closure.


Vedat Verter, PhD

Latest:

Impact of Psychiatric Follow-Up Frequency on Outcomes and Waiting Times

Naturally occurring variations in appointment frequencies do not appear to have a major impact on clinical outcomes, but they significantly affect waiting times.


April W. Armstrong, MD, MPH

Latest:

Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review

This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.


Avni Kothari, MS

Latest:

Reducing Readmissions in the Safety Net Through AI and Automation

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.


Polly McCracken, MA

Latest:

A Scoping Review of US Insurers’ Use of Patient-Reported Outcomes

This scoping review found 350 articles that discuss US health insurance providers’ use of patient-reported outcomes about health-related quality of life.


Anurag Pant, MA

Latest:

Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.


David Hutton

Latest:

Atsena Therapeutics and Nippon Shinyaku Enter Exclusive License Agreement for ATSN-101

Atsena Therapeutics and Nippon Shinyaku have formed an exclusive licensing agreement for ATSN-101, a gene therapy for Leber congenital amaurosis (LCA1). Nippon Shinyaku will commercialize ATSN-101 in the US and Japan, while Atsena retains global rights outside these territories.


Andrew Kuykendall, MD  | Image Credit: © Moffitt Cancer Center
Andrew Kuykendall, MD

Latest:

Fatigue, Quality of Life Improve With Rusfertide: Andrew Kuykendall, MD

Andrew Kuykendall, MD, is an investigator on the phase 3 VERIFY trial (NCT05210790), findings from which demonstrate the safety, reliability, and effectiveness of rusfertide to treat polycythemia vera.


Jaehong Kim, PhD

Latest:

Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo